Genetic background determines the extent of atherosclerosis in ApoE-deficient mice.

Two strains of ApoE-deficient mice were found to have markedly different plasma lipoprotein profiles and susceptibility to atherosclerosis when fed either a low-fat chow or a high-fat Western-type diet. FVB/NJ ApoE-deficient (FVB E0) mice had higher total cholesterol, HDL cholesterol, ApoA1, and ApoA2 levels when compared with C57BL/6J ApoE-deficient (C57 E0) mice. At 16 weeks of age, mean aortic root atherosclerotic lesion area was 7- to 9-fold higher in chow diet-fed C57 E0 mice and 3.5-fold higher in Western diet-fed C57 E0 mice compared with FVB E0 mice fed similar diets. Lesion area in chow diet-fed first-generation mice from a strain intercross was intermediate in size compared with parental values. The distribution of the lesion area in 150 chow diet-fed second-generation progeny spanned the range of the lesion area in both parental strains. There were no correlations between total cholesterol, non-HDL cholesterol, HDL cholesterol, ApoA1, ApoA2, ApoJ, or anti-cardiolipin antibodies and lesion area in the second-generation progeny. Thus, a genomic approach may succeed in identifying the genes responsible for the variation in atherosclerosis susceptibility in these 2 strains of ApoE-deficient mice, which could not be explained by measured plasma parameters.

[1]  D. Witte,et al.  Plasminogen deficiency accelerates vessel wall disease in mice predisposed to atherosclerosis. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[2]  L. Paka,et al.  Subendothelial retention of lipoprotein (a). Evidence that reduced heparan sulfate promotes lipoprotein binding to subendothelial matrix. , 1997, The Journal of clinical investigation.

[3]  J. Gamble,et al.  High-density lipoproteins inhibit cytokine-induced expression of endothelial cell adhesion molecules. , 1995, Arteriosclerosis, thrombosis, and vascular biology.

[4]  B. Paigen,et al.  Effect of 3-methylcholanthrene on the development of aortic lesions in mice. , 1985, Cancer research.

[5]  J. Lough,et al.  Pathology of atherosclerosis in cholesterol-fed, susceptible mice. , 1991, Atherosclerosis.

[6]  Michael Ginsberg,et al.  Decreased atherosclerosis in mice deficient in both macrophage colony-stimulating factor (op) and apolipoprotein E. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[7]  A. Lusis,et al.  Complex genetic control of HDL levels in mice in response to an atherogenic diet. Coordinate regulation of HDL levels and bile acid metabolism. , 1997, The Journal of clinical investigation.

[8]  E. L. Green,et al.  Biology of the Laboratory Mouse , 1942 .

[9]  P. Kovacs,et al.  Alleles of the spontaneously hypertensive rat decrease blood pressure at loci on chromosomes 4 and 13. , 1997, Biochemical and biophysical research communications.

[10]  E. Rubin,et al.  Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells , 1992, Cell.

[11]  B. Paigen,et al.  Variation in susceptibility to atherosclerosis among inbred strains of mice. , 1985, Atherosclerosis.

[12]  N. Tolbert,et al.  A modification of the Lowry procedure to simplify protein determination in membrane and lipoprotein samples. , 1978, Analytical biochemistry.

[13]  D. Coleman,et al.  Effect of Genetic Background on the Therapeutic Effects of Dehydroepiandrosterone (DHEA) in Diabetes-Obesity Mutants and in Aged Normal Mice , 1984, Diabetes.

[14]  B. Taylor,et al.  Obesity QTLs on mouse chromosomes 2 and 17. , 1997, Genomics.

[15]  L. Vogt,et al.  Diabetes and Hypertension in Rodent Models a , 1997, Annals of the New York Academy of Sciences.

[16]  C. Warden,et al.  Mapping of mouse obesity genes: A generic approach to a complex trait. , 1997, The Journal of nutrition.

[17]  A. Lusis,et al.  Overexpression of apolipoprotein AII in transgenic mice converts high density lipoproteins to proinflammatory particles. , 1997, The Journal of clinical investigation.

[18]  R. Ross,et al.  ApoE-deficient mice develop lesions of all phases of atherosclerosis throughout the arterial tree. , 1994, Arteriosclerosis and thrombosis : a journal of vascular biology.

[19]  C. McFarland,et al.  Genetic analysis of the difference in diet-induced atherosclerosis between the inbred mouse strains SM/J and NZB/BINJ. , 1998, Arteriosclerosis, thrombosis, and vascular biology.

[20]  J. Qiao,et al.  Influence of the apoA-II gene locus on HDL levels and fatty streak development in mice. , 1993, Arteriosclerosis and thrombosis : a journal of vascular biology.

[21]  J. Qiao,et al.  Atherosclerosis in transgenic mice overexpressing apolipoprotein A-II. , 1993, Science.

[22]  A. Lusis,et al.  Ath-1, a gene determining atherosclerosis susceptibility and high density lipoprotein levels in mice. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[23]  J. Witztum,et al.  Cloning of monoclonal autoantibodies to epitopes of oxidized lipoproteins from apolipoprotein E-deficient mice. Demonstration of epitopes of oxidized low density lipoprotein in human plasma. , 1996, The Journal of clinical investigation.

[24]  R. Williams,et al.  Quantitative assessment of atherosclerotic lesions in mice. , 1987, Atherosclerosis.

[25]  D K Burns,et al.  Massive xanthomatosis and atherosclerosis in cholesterol-fed low density lipoprotein receptor-negative mice. , 1994, The Journal of clinical investigation.

[26]  T. Takagi,et al.  Genetic dissection of ``OLETF'', a rat model for non-insulin-dependent diabetes mellitus , 1998, Mammalian Genome.

[27]  T. Roderick,et al.  FVB/N: an inbred mouse strain preferable for transgenic analyses. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[28]  N. Maeda,et al.  Hepatic Lipase Deficiency Increases Plasma Cholesterol but Reduces Susceptibility to Atherosclerosis in Apolipoprotein E-deficient Mice* , 1997, The Journal of Biological Chemistry.

[29]  A Daugherty,et al.  The effects of total lymphocyte deficiency on the extent of atherosclerosis in apolipoprotein E-/- mice. , 1997, The Journal of clinical investigation.

[30]  R. Terkeltaub,et al.  Antiphospholipid antibodies are directed against epitopes of oxidized phospholipids. Recognition of cardiolipin by monoclonal antibodies to epitopes of oxidized low density lipoprotein. , 1996, The Journal of clinical investigation.

[31]  Yukiko Kurihara,et al.  A role for macrophage scavenger receptors in atherosclerosis and susceptibility to infection , 1997, Nature.

[32]  C. Drake,et al.  Effect of genetic background on the contribution of New Zealand black loci to autoimmune lupus nephritis. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[33]  K. Elkon,et al.  IgG anti-cardiolipin antibodies in murine lupus. , 1989, Clinical and experimental immunology.

[34]  D. Witte,et al.  Fibrinogen deficiency is compatible with the development of atherosclerosis in mice. , 1998, The Journal of clinical investigation.

[35]  P. Libby,et al.  Role of macrophage colony-stimulating factor in atherosclerosis: studies of osteopetrotic mice. , 1997, The American journal of pathology.

[36]  V. Ord,et al.  ApoE-deficient mice are a model of lipoprotein oxidation in atherogenesis. Demonstration of oxidation-specific epitopes in lesions and high titers of autoantibodies to malondialdehyde-lysine in serum. , 1994, Arteriosclerosis and thrombosis : a journal of vascular biology.

[37]  A. Lusis,et al.  Genetic control of inflammatory gene induction and NF-kappa B-like transcription factor activation in response to an atherogenic diet in mice. , 1993, The Journal of clinical investigation.

[38]  L. Espinoza,et al.  Induction of Experimental Antiphospholipid Antibody Syndrome in PL/J Mice Following Immunization With β2GPI , 1997, American journal of reproductive immunology.

[39]  J. Breslow,et al.  Human apolipoprotein A-I gene expression increases high density lipoprotein and suppresses atherosclerosis in the apolipoprotein E-deficient mouse. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[40]  K. Williams,et al.  The response-to-retention hypothesis of early atherogenesis. , 1995, Arteriosclerosis, thrombosis, and vascular biology.

[41]  I. Goldberg,et al.  Endothelial cells and atherosclerosis: lipoprotein metabolism, matrix interactions, and monocyte recruitment , 1994, Current opinion in lipidology.

[42]  J. Fruchart,et al.  Detection of autoantibodies against oxidized low-density lipoproteins and of IgG-bound low density lipoproteins in patients with coronary artery disease. , 1995, Clinica chimica acta; international journal of clinical chemistry.

[43]  N. Maeda,et al.  Generation of mice carrying a mutant apolipoprotein E gene inactivated by gene targeting in embryonic stem cells. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[44]  G. Fonarow,et al.  Mildly oxidized LDL induces an increased apolipoprotein J/paraoxonase ratio. , 1997, The Journal of clinical investigation.

[45]  D. Ganten,et al.  Salt susceptibility maps to chromosomes 1 and 17 with sex specificity in the Sabra rat model of hypertension. , 1998, Hypertension.

[46]  E. Skamene,et al.  ATH-3, a new gene for atherosclerosis in the mouse. , 1989, Clinical and investigative medicine. Medecine clinique et experimentale.

[47]  S. Thenen,et al.  Influence of age and genetic background on in vivo fatty acid synthesis in obese (ob/ob) mice. , 1980, Biochimica et biophysica acta.

[48]  E M Rubin,et al.  Quantitation of atherosclerosis in murine models: correlation between lesions in the aortic origin and in the entire aorta, and differences in the extent of lesions between sexes in LDL receptor-deficient and apolipoprotein E-deficient mice. , 1995, Journal of lipid research.

[49]  J. Mcneish,et al.  Expression of human lecithin:cholesterol acyltransferase in transgenic mice: effects on cholesterol efflux, esterification, and transport. , 1997, Journal of lipid research.

[50]  P. Kovacs,et al.  Mapping of quantitative trait loci for body weight on chromosomes 1 and 4 in the rat , 1998, Biochemistry and molecular biology international.

[51]  C. Ebeling,et al.  Theoretical and empirical issues for marker-assisted breeding of congenic mouse strains , 1997, Nature Genetics.

[52]  D. Shih,et al.  Mice lacking serum paraoxonase are susceptible to organophosphate toxicity and atherosclerosis , 1998, Nature.

[53]  K. Hummel,et al.  Symposium IV: Diabetic syndrome in animals. Influence of genetic background on the expression of mutations at the diabetes locus in the mouse. II. Studies on background modifiers. , 1975, Israel journal of medical sciences.

[54]  B. Paigen,et al.  Ath-2, a second gene determining atherosclerosis susceptibility and high density lipoprotein levels in mice. , 1989, Genetics.

[55]  H. Waldmann,et al.  Strain variation in susceptibility to monoclonal antibody-induced transplantation tolerance. , 1997, Transplantation.

[56]  N. Samani,et al.  Successful isolation of a rat chromosome 1 blood pressure quantitative trait locus in reciprocal congenic strains. , 1998, Hypertension.

[57]  B. Paigen,et al.  Atherosclerosis susceptibility differences among progenitors of recombinant inbred strains of mice. , 1990, Arteriosclerosis.

[58]  B. Taylor,et al.  Detection of obesity QTLs on mouse chromosomes 1 and 7 by selective DNA pooling. , 1996, Genomics.